Researchers at the University of Kentucky want to determine whether the “erectile dysfunction drug” Cialis (tadalafil) or the “overactive-bladder drug” Myrbetriq (mirabegron) will improve blood sugar and metabolism.
You may be eligible for this research study if you are:
• Overweight (BMI more than 27)
• Age 35-65 years old
• Are not on medications for diabetes
• Have not had a previous heart attack or severe heart condition
Participants will receive compensation for their time.
If you are interested in learning more about this study, please complete this form:
